Chemiluminescent Presentation l4

Embed Size (px)

Citation preview

  • 8/2/2019 Chemiluminescent Presentation l4

    1/26

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    2/26

    What is chemiluminescence?

    It is the generation of electromagnetic

    radiation in the form of visible light by the

    release of light from a chemical reaction.

    The light can, in principle, be emitted in the

    ultraviolet, visible or infrared region, those

    emitting visible light are the most common.

    They are also the most interesting and useful.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    3/26

    Types of chemiluminescent reactions

    Chemiluminescent reactions (CL):Chemical reactionsusing synthetic compounds and usually involving a highlyoxidized species such as a peroxide.

    Bioluminescent reactions: Light-emitting reactions arisingfrom a living organism, such as the firefly or jellyfish.

    Electrochemiluminescent reactions: Light-emittingreactions which take place by the use of electrical current.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    4/26

    PRINCIPLE

    The basic principle consists of light-producing reaction

    involves the excitation of a molecule from its ground state

    into an excited state.

    The energy for this excitation is generated through a

    chemical reaction. Upon returning to ground state, a photon of light is

    emitted from the molecule with a characteristic

    wavelength and frequency, and energy equal to the

    transition taking place.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    5/26

    Contd

    The intensity of the emitting light is

    proportional to the amount of enzyme present

    and is directly related to the amount of the

    analyte in the sample

    A chemiluminescent reaction occurs

    between the compound, luminol and

    several other chemicals.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    6/26

    Contd

    Therefore, most chemiluminescent reactions (CL)use oxygen, hydrogen peroxide, or similar

    potential oxidants.

    As a principle in CL reactions, at least two

    reagents, A and B react to form a product C, some

    fraction of which is present in an electronically

    excited state, C*, which may subsequently relax

    to the ground state emitting a photon: A + B C* C + photon of light

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    7/26

    PROCEDURES

    PROCEDURE FOR REAGENT PREPARATION

    Materials and reagents

    1. Sodium Carbonate 10 hydrate Na2CO3H2O

    2. Sodium Bicarbonate NaHCO33. Luminol (5-amino-2, 3-dihydrophthalazine-1, 4-Dione)

    4. Ammonium Carbonate Monohydrate (NH4)2CO3H2O

    5. Copper (II) Sulfate 5 hydrate CuSO45H2O

    6. Erlenmeyer Flasks

    7. Glass beaker

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    8/26

    PROCEDURE FOR REAGENTS PREPARATION

    1. Add 500mL of deionized water to a 1L Erlenmeyer

    flask labeled solution A.2. Add 10.7g of sodium carbonate to solution A. Stir.

    3. Add 0.2g luminol to solution A. Stir.

    4. Add 24.0g of Sodium Bicarbonate to solution A. Stir.5. Add 0.5g of Ammonium Carbonate to solution A.

    Stir.

    6. Add 0.4g of Copper Sulfate to solution A. Stir.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    9/26

    Cont

    7. Add Deionized water to Solution A flask to a final volume of1L.

    8. Add 950mL of deionized water to a 1L Erlenmeyer flask

    labeled solution B

    9. Add 50mL 3% hydrogen peroxide to solution B. Stir.10. Pour equal amounts (about 100mL) of Solution A and

    Solution B into separate beakers.

    11. Dim the lights and then mix the two solutions in the beakers

    together.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    10/26

    ASSAY PROCEDURE

    Materials

    Antibody-coated microtiter wells.

    Set of Reference Standards

    Enzyme Conjugate Reagent.

    Wash Buffer.

    Chemiluminescence Reagent A.

    Chemiluminescence Reagent B.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    11/26

    Procedure

    1. Secure the desired number of coated wells in

    the holder.

    2. Dispense standards, specimens, and controls

    into appropriate wells.

    3. Dispense Enzyme Conjugate Reagent into

    each well.

    4. Thoroughly mix. It is very important to have

    complete mixing in this step.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    12/26

    Cont

    5.Incubate at room temperature (18-22C) forabout 60 minutes.

    6.Rinse and flick the microtiter wells withwashing solution and final 1 time with distilled

    water.

    7.Strike the wells sharply onto absorbent paperto remove residual water droplets.

    8.Dispense Chemiluminescence substratesolution into each well. Then gently mix for 5seconds.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    13/26

    9.Read wells with a chemiluminescence microwell

    reader 5 minutes later. (Between 5 and 20 min after

    dispensed the substrates).

    10.After a solution of chemiluminescent substrate is

    then added and read relative light units (RLU) in a

    Luminometers.The intensity of the emitting light is

    proportional to the amount of enzyme present and isdirectly related to the amount of the hormone in the

    sample.

    By reference to a series of standards assayed in the same

    way, the concentration of the analyte in the unknown

    sample is quantified.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    14/26

    Microwell Plates

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    15/26

    SENSITIVITY

    Chemiluminescent assays are very sensitive.

    Sensitivity refers to the lowest level at which something canbe reliably detected. The analyte can be labeled with somedetectable tag, such as a chemiluminescent compound or anenzyme. The analyte can also be detected by a specific

    binding reaction with an affinity binding partner having alabel.

    Example: The mean TSH values based on 160 random

    normal adult blood samples, is 1.6 (0.4-7.0) IU/ml.The minimum detectable concentration of TSH by thischemiluminescent assay is estimated to be 0.2 IU/ml.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    16/26

    DETECTORS

    1. Liquid chromatography detectors

    High-performance liquid chromatography (HPLC) is a

    form of liquid chromatography to separate compounds

    that are dissolved in solution.It permits the separation, detection and estimation of a

    wide range of compounds with a high degree of

    specificity.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    17/26

    The compounds analysed are water soluble ,non-volatile

    and thermal unstable.

    The separation is achieved by competitive distributionof the sample between mobile phase and stationary

    phase.

    The most used is the ultraviolet detector at fixed or

    variable wavelength but fluorimetric and

    electrochemical detectors are also available.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    18/26

    2. Gas chromatography detectors

    Gas chromatography is a chromatographic technique

    that can be used to separate organic compounds thatare volatile. A gas chromatograph consists of a

    flowing mobile phase, an injection port, a separation

    column containing the stationary phase, a detector,

    and a data recording system.

    The organic compounds are separated due to

    differences in their partitioning behavior between the

    mobile gas phase and the stationary phase in thecolumn.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    19/26

    Figure

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    20/26

    CLINICAL UTILITY

    The chemiluminescence techniques have been applied

    to a great variety of analytes and samples analysis in

    clinical field.

    The following figure summarises the other important

    applications of CL methods in several fields.

    4/4/2012 CHEMICAL PATHOLOGY WORK

    CHEMILUMINESCENCE APPLICATIONS

  • 8/2/2019 Chemiluminescent Presentation l4

    21/26

    CHEMILUMINESCENCE APPLICATIONS

    Clinical chemistry Drug analysis

    Diagnostic tool in medicine Biomedical research

    Radical scavenging and antioxidant effect in

    oxidative stress...

    Analytical chemistry High sensitive trace analysis

    Detector for HPLC

    Capillary electrophoresis,

    Supercritical fluids,

    Environmental chemistry Agricultural analysis

    Air analysis

    Water analysis

    Soil analysis

    Food chemistry Quality control

    Oxidation and deterioration

    Olive oil

    Residue determination

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    22/26

    ADVANTAGES

    Rapid measurement

    Wide measuring range

    Controlled reactions and stability

    High Sensitivity and Linearity over a Broad ConcentrationRange

    Good Reproducibility and High Specificity for the analyte

    Measurements Possible in Turbid or Colored Samples, Even atExtreme pH

    4/4/2012CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    23/26

    Moderate Running Costs

    Low sample volume

    Measurement of chemiluminescence is not a ratio

    measurement in the way fluorescence and absorption or colors

    are.

    Most samples have no 'background' signal, i.e. they do not

    themselves emit light. No interfering signal limits sensitivity.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    24/26

    DISADVANTAGES

    Provides Limited Structural Information

    Limited Sample Throughput

    High Purchase Price for Detectors.

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    25/26

    REFERENCES

    1. Baker&Silvertons :Introduction to medical laboratory

    technology 7th edition.

    2. Albrecht, H.O. (1999). Chemiluminescence of

    aminophthalic hydrazide. Z. Phys. Chem. 136, 321.

    3. Altinoz, S. and Dursun, O.O. (2000). Determination ofnimesulide in pharmaceutical dosage forms by second

    order derivative UV spectrophotometry. J. Pharm.

    Biomed. Anal., 22, 175-182.

    4. T. Nieman, Chemiluminescence: Theory andInstrumentation, Overview, inEncyclopedia of Analytical

    Science, Academic Press, Orlando, 608-613 (1995).

    4/4/2012 CHEMICAL PATHOLOGY WORK

  • 8/2/2019 Chemiluminescent Presentation l4

    26/26

    GO AND READ U WILL

    KNOW MORE

    4/4/2012 CHEMICAL PATHOLOGY WORK